Polymeric vehicles often exhibit batch-to-batch variations
due
to polydispersity, limiting their reproducibility for biomedical applications.
In contrast, polyhedral oligomeric silsesquioxane (POSS) has emerged
as an attractive candidate for drug delivery due to its precise chemical
structure and rigid molecular shape. A promising strategy to enhance
drug efficacy while reducing systemic toxicity is the development
of multi-stimuli-responsive delivery systems capable of targeted drug
release at a disease site. Herein, we developed a drug delivery platform
based on POSS–polymer conjugates. By functionalizing the POSS
with amino groups and establishing B–N coordination with boronic
acids, the nanoparticles (NPs) exhibit responsive behavior to stimuli,
including adenosine-5′-triphosphate (ATP), acidic pH, and nucleophilic
reagents. We successfully encapsulated two boronic acid-containing
molecules: tetraphenylethylene (TPE), serving as a fluorescent probe,
and bortezomib (BTZ), an anticancer drug. The TPE@NPs were employed
to visualize the cellular uptake of NPs by tumor cells, while the
BTZ@NPs exhibited increased cytotoxicity in tumor cells compared with
normal cells. This POSS–PEG conjugate offers a nanoparticle
platform for encapsulating versatile boronic acid-containing molecules,
thereby enhancing drug efficacy while minimizing systemic toxicity.
Given the wide-ranging applications of boronic acid-containing molecules
in biomedicine, our platform holds significant promise for the development
of intelligent drug delivery systems for diagnostics and therapeutics.